SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel ophthalmic surgical devices and sustained pharmaceutical ther…
Mimics Enlight Cardiovascular Planning Software Gets FDA Clearance
Materialise, a 3D printing company with a focus on patient-specific parts, has received FDA clearance for its Mimics Enlight cardiovascular planning software suite. The product’s initial application will be in planning complex transcatheter mitral valve replacement (TMVR) procedures. Developed with the help of the Henry Ford Health System in (Read more...)
VIDEO: Cataract surgeons focus on dry eye, reduced drops, new IOLs
KIAWAH ISLAND, S.C. — At the Kiawah Eye meeting here, John A. Hovanesian, MD, addresses the latest in cataract surgery, including the management of dry eye, reducing eye drop burden and new technologies in IOLs.
eMacula Augmented Reality for Vision Impaired: Interview with Steve Willey, CEO of Innovega
Innovega Inc., a systems engineering and lens development company with offices in Washington and California, has created eMacula, a new generation of eyewear that combines smart contact lenses and stylish, lightweight glasses. The system will be tailored to the needs of vision impaired patients who will benefit from both lens-based vision correctio (Read more...)
Alcon Takes Center Stage with Contact Lens Innovations and the iLUX® System at the 2019 Optometry’s Meeting
FORT WORTH, Texas–(BUSINESS WIRE)–Alcon, the global leader in eye care, will launch DAILIES® COLORS contact lenses at the 2019 Optometry’s Meeting, as well as give attendees a preview of PRECISION1™ contact lenses coming soon to the US. These innovat…
Tumors Grown in 3D from Cancer Patient Samples for Drug Screening
Cancerous tumors can be very inconsistent in how they respond to different therapies. While the tumor of one patient can rapidly shrink when exposed to a given medication, another patient suffering from the same kind of tumor may not get any benefit from that same drug. This phenomenon highlights why personalized medicine is such an […]